Reflect Scientific’s Cryometrix Suitable for COVID-19 Vax Air Transport

Reflect Scientific, Inc., a provider of products and services for the biotechnology, pharmaceutical, and transportation industries, has been granted a patent by the U.S. Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling.

The large shipping system is capable of carrying many thousands of doses of vaccines and utilizes the commercial Cryometrix cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.

Mr. Kim Boyce, CEO of Reflect Scientific, said, “Reflect Scientific is now working with organizations such as the governments’ Operation Warp Speed and air carriers that have the expertise to utilize this storage system for specific customized applications.”